Related references
Note: Only part of the references are listed.Update on Typical and Atypical Antipsychotic Drugs
Herbert Y. Meltzer
ANNUAL REVIEW OF MEDICINE, VOL 64 (2013)
Blonanserin reverses the phencyclidine (PCP)-induced impairment in novel object recognition (NOR) in rats: Role of indirect 5-HT1A partial agonism
M. Horiguchi et al.
BEHAVIOURAL BRAIN RESEARCH (2013)
Periadolescent Exposure to the NMDA Receptor Antagonist MK-801 Impairs the Functional Maturation of Local GABAergic Circuits in the Adult Prefrontal Cortex
Daniel R. Thomases et al.
JOURNAL OF NEUROSCIENCE (2013)
Egis-11150: A candidate antipsychotic compound with procognitive efficacy in rodents
Istvan Gacsalyi et al.
NEUROPHARMACOLOGY (2013)
5-HT1A Receptor Agonists Enhance Pyramidal Cell Firing in Prefrontal Cortex Through a Preferential Action on GABA Interneurons
Laia Llado-Pelfort et al.
CEREBRAL CORTEX (2012)
Ketamine alters the neurogenesis of rat cortical neural stem progenitor cells
Chaoxuan Dong et al.
CRITICAL CARE MEDICINE (2012)
Treating Impaired Cognition in Schizophrenia
H. M. Ibrahim et al.
CURRENT PHARMACEUTICAL BIOTECHNOLOGY (2012)
Serotonin Receptors as Targets for Drugs Useful to Treat Psychosis and Cognitive Impairment in Schizophrenia
H. Y. Meltzer et al.
CURRENT PHARMACEUTICAL BIOTECHNOLOGY (2012)
The 5-HT7 receptor in learning and memory
Amanda J. Roberts et al.
HIPPOCAMPUS (2012)
Serotonin 5-HT7 Receptor Blockade Reverses Behavioral Abnormalities in PACAP-Deficient Mice and Receptor Activation Promotes Neurite Extension in Primary Embryonic Hippocampal Neurons Therapeutic Implications for Psychiatric Disorders
Minako Tajiri et al.
JOURNAL OF MOLECULAR NEUROSCIENCE (2012)
Restoration of dopamine release deficits during object recognition memory acquisition attenuates cognitive impairment in a triple transgenic mice model of Alzheimer's disease
Kioko Guzman-Ramos et al.
LEARNING & MEMORY (2012)
Asenapine effects on cognitive and monoamine dysfunction elicited by subchronic phencyclidine administration
John D. Elsworth et al.
NEUROPHARMACOLOGY (2012)
NMDA receptors, cognition and schizophrenia - Testing the validity of the NMDA receptor hypofunction hypothesis
Gary Gilmour et al.
NEUROPHARMACOLOGY (2012)
Prevention of the Phencyclidine-Induced Impairment in Novel Object Recognition in Female Rats by Co-Administration of Lurasidone or Tandospirone, a 5-HT1A Partial Agonist
Masakuni Horiguchi et al.
NEUROPSYCHOPHARMACOLOGY (2012)
Hippocampal neurotransmitter efflux during one-trial novel object recognition in rats
Emily M. Stanley et al.
NEUROSCIENCE LETTERS (2012)
Spontaneous object recognition and its relevance to schizophrenia: a review of findings from pharmacological, genetic, lesion and developmental rodent models
L. Lyon et al.
PSYCHOPHARMACOLOGY (2012)
The role of 5-HT1A receptors in phencyclidine (PCP)-induced novel object recognition (NOR) deficit in rats
M. Horiguchi et al.
PSYCHOPHARMACOLOGY (2012)
Pimavanserin, a selective serotonin (5-HT)2A-inverse agonist, enhances the efficacy and safety of risperidone, 2 mg/day, but does not enhance efficacy of haloperidol, 2 mg/day: Comparison with reference dose risperidone, 6 mg/day
Herbert Y. Meltzer et al.
SCHIZOPHRENIA RESEARCH (2012)
The Neurodevelopmental Hypothesis of Schizophrenia Convergent Clues from Epidemiology and Neuropathology
Michael Piper et al.
PSYCHIATRIC CLINICS OF NORTH AMERICA (2012)
The Novel Antipsychotic Drug Lurasidone Enhances N-Methyl-D-aspartate Receptor-Mediated Synaptic Responses
Eunice Y. Yuen et al.
MOLECULAR PHARMACOLOGY (2012)
Animal Model for Schizophrenia That Reflects Gene-Environment Interactions
Taku Nagai et al.
BIOLOGICAL & PHARMACEUTICAL BULLETIN (2011)
5-HT6 receptor and cognition
Xabier Codony et al.
CURRENT OPINION IN PHARMACOLOGY (2011)
Persisting cognitive deficits induced by low-dose, subchronic treatment with MK-801 in adolescent rats
Ji-Tao Li et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2011)
Synaptic changes in the brain of subjects with schizophrenia
Gabor Faludi et al.
INTERNATIONAL JOURNAL OF DEVELOPMENTAL NEUROSCIENCE (2011)
The Role of 5-Hydroxytryptamine 7 Receptors in the Phencyclidine-Induced Novel Object Recognition Deficit in Rats
M. Horiguchi et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2011)
Declarative memory deficits and schizophrenia: Problems and prospects
William S. Stone et al.
NEUROBIOLOGY OF LEARNING AND MEMORY (2011)
Evidence for a SULT4A1 haplotype correlating with baseline psychopathology and atypical antipsychotic response
Timothy L. Ramsey et al.
PHARMACOGENOMICS (2011)
Schizophrenia: susceptibility genes, dendritic-spine pathology and gray matter loss
M. R. Bennett
PROGRESS IN NEUROBIOLOGY (2011)
Asenapine improves phencyclidine-induced object recognition deficits in the rat: evidence for engagement of a dopamine D1 receptor mechanism
Shikha Snigdha et al.
PSYCHOPHARMACOLOGY (2011)
Effects of low-dose d-serine on recognition and working memory in mice
Patricia Bado et al.
PSYCHOPHARMACOLOGY (2011)
Interaction of mGlu2/3 agonism with clozapine and lurasidone to restore novel object recognition in subchronic phencyclidine-treated rats
Masakuni Horiguchi et al.
PSYCHOPHARMACOLOGY (2011)
The role of serotonin in the NMDA receptor antagonist models of psychosis and cognitive impairment
Herbert Y. Meltzer et al.
PSYCHOPHARMACOLOGY (2011)
Tonic excitation or inhibition is set by GABAA conductance in hippocampal interneurons
Inseon Song et al.
NATURE COMMUNICATIONS (2011)
Impaired Visual Object Processing Across an Occipital-Frontal-Hippocampal Brain Network in Schizophrenia An Integrated Neuroimaging Study
Pejman Sehatpour et al.
ARCHIVES OF GENERAL PSYCHIATRY (2010)
Tryptophan depletion impairs object-recognition memory in the rat: Reversal by risperidone
Trisha A. Jenkins et al.
BEHAVIOURAL BRAIN RESEARCH (2010)
Dopamine release induced by atypical antipsychotics in prefrontal cortex requires 5-HT1A receptors but not 5-HT2A receptors
Analia Bortolozzi et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2010)
A novel delayed non-match to sample object recognition task that allows simultaneous in vivo microdialysis
Jouni Ihalainen et al.
JOURNAL OF NEUROSCIENCE METHODS (2010)
Attenuation of Phencyclidine-Induced Object Recognition Deficits by the Combination of Atypical Antipsychotic Drugs and Pimavanserin (ACP 103), a 5-Hydroxytryptamine2A Receptor Inverse Agonist
S. Snigdha et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2010)
Animal models of cognitive dysfunction and negative symptoms of schizophrenia: Focus on NMDA receptor antagonism
Joanna C. Neill et al.
PHARMACOLOGY & THERAPEUTICS (2010)
Sertindole improves sub-chronic PCP-induced reversal learning and episodic memory deficits in rodents: involvement of 5-HT6 and 5-HT2A receptor mechanisms
Nagi Idris et al.
PSYCHOPHARMACOLOGY (2010)
Neonatal Phencyclidine Treatment in Mice Induces Behavioral, Histological and Neurochemical Abnormalities in Adulthood
Akiko Nakatani-Pawlak et al.
BIOLOGICAL & PHARMACEUTICAL BULLETIN (2009)
D1-like receptor activation improves PCP-induced cognitive deficits in animal models: Implications for mechanisms of improved cognitive function in schizophrenia
Samantha L. McLean et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2009)
Subchronic Effects of Phencyclidine on Dopamine and Serotonin Receptors: Implications for Schizophrenia
Yong Kee Choi et al.
JOURNAL OF MOLECULAR NEUROSCIENCE (2009)
Asenapine: a novel psychopharmacologic agent with a unique human receptor signature
M. Shahid et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2009)
alpha(7) Nicotinic acetylcholine receptor activation prevents behavioral and molecular changes induced by repeated phencyclidine treatment
Morten S. Thomsen et al.
NEUROPHARMACOLOGY (2009)
Using the MATRICS to guide development of a preclinical cognitive test battery for research in schizophrenia
Jared W. Young et al.
PHARMACOLOGY & THERAPEUTICS (2009)
Rapid modulation of spine morphology by the 5-HT2A serotonin receptor through kalirin-7 signaling
Kelly A. Jones et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Aripiprazole ameliorates phencyclidine-induced impairment of recognition memory through dopamine D-1 and serotonin 5-HT1A receptors
Taku Nagai et al.
PSYCHOPHARMACOLOGY (2009)
Role of 5-HT receptor mechanisms in sub-chronic PCP-induced reversal learning deficits in the rat
Samantha L. McLean et al.
PSYCHOPHARMACOLOGY (2009)
The 5-HT7 receptor and disorders of the nervous system: an overview
Peter B. Hedlund
PSYCHOPHARMACOLOGY (2009)
Improvement of phencyclidine-induced social behaviour deficits in rats:: Involvement of 5-HT1A receptors
Shikha Snigdha et al.
BEHAVIOURAL BRAIN RESEARCH (2008)
Evaluation of a neurodevelopmental model of schizophrenia - Early postnatal PCP treatment in attentional set-shifting
Brian Villumsen Broberg et al.
BEHAVIOURAL BRAIN RESEARCH (2008)
D-Serine and a glycine transporter inhibitor improve MK-801-induced cognitive deficits in a novel object recognition test in rats
Jun-Ichi Karasawa et al.
BEHAVIOURAL BRAIN RESEARCH (2008)
Phencyclidine-induced cognitive deficits in mice are improved by subsequent subchronic administration of the antipsychotic drug perospirone:: Role of serotonin 5-HT1A receptors
Hiroko Hagiwara et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2008)
Activation of 5-HT2A/C receptors counteracts 5-HT1A regulation of N-methyl-D-aspartate receptor channels in pyramidal neurons of prefrontal cortex
Eunice Y. Yuen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Asenapine increases dopamine, norepinephrine, and acetylcholine efflux in the rat medial prefrontal cortex and hippocampus
Mei Huang et al.
NEUROPSYCHOPHARMACOLOGY (2008)
Effects of neonatal repeated MK-801 treatment on delayed non matching-to-position responses in rats
Kouichi Kawabe et al.
NEUROREPORT (2008)
Characterization of SSR103800, a selective inhibitor of the glycine transporter-1 in models predictive of therapeutic activity in schizophrenia
Denis Boulay et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2008)
Atypical antipsychotics attenuate a sub-chronic PCP-induced cognitive deficit in the novel object recognition task in the rat
B. Grayson et al.
BEHAVIOURAL BRAIN RESEARCH (2007)
Stimulation of 5-HT1A, 5-HT1B, 5-HT2A/2C, 5-HT3 and 5-HT4 receptors or 5-HT uptake inhibition:: Short- and long-term memory
Alfredo Meneses
BEHAVIOURAL BRAIN RESEARCH (2007)
The Cognitive and Negative Symptoms in Schizophrenia, Trial (CONSIST): The efficacy of glutamatergic agents for negative symptoms and cognitive impairments
Robert W. Buchanan et al.
AMERICAN JOURNAL OF PSYCHIATRY (2007)
Neurocognitive effects of antipsychotic medications in patients with chronic schizophrenia in the CATIE trial
Richard S. E. Keefe et al.
ARCHIVES OF GENERAL PSYCHIATRY (2007)
SSR180711, a novel selective alpha 7 nicotinic receptor partial agonist: (II) efficacy in experimental models predictive of activity against cognitive symptoms of schizophrenia
Philippe Pichat et al.
NEUROPSYCHOPHARMACOLOGY (2007)
Sub-chronic psychotomimetic phencyclidine induces deficits in reversal learning and alterations in parvalbumin-immunoreactive expression in the rat
Z. Abdul-Monim et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2007)
Cortical serotonin7, 1D and 1F receptors:: Effects of schizophrenia, suicide and antipsychotic drug treatment
Brian Dean et al.
SCHIZOPHRENIA RESEARCH (2006)
Neurocognitive performance and functional disability in the psychosis prodrome
Tara A. Niendam et al.
SCHIZOPHRENIA RESEARCH (2006)
Behavioural effects of neonatal lesions of the medial prefrontal cortex and subchronic pubertal treatment with phencyclidine of adult rats
K Schwabe et al.
BEHAVIOURAL BRAIN RESEARCH (2006)
ACP-103, a 5-HT2A/2C inverse agonist, potentiates haloperidol-induced dopamine release in rat medial prefrontal cortex and nucleus accumbens
Z Li et al.
PSYCHOPHARMACOLOGY (2005)
Involvement of 5-HT1A receptors in prefrontal cortex in the modulation of dopaminergic activity:: Role in atypical antipsychotic action
L Díaz-Mataix et al.
JOURNAL OF NEUROSCIENCE (2005)
Neurochemical, electrophysiological and pharmacological profiles of the selective inhibitor of the glycine transporter-I SSR504734, a potential new type of antipsychotic
R Depoortère et al.
NEUROPSYCHOPHARMACOLOGY (2005)
Modulation of recognition and temporal order memory retrieval by dopamine D1 receptor in rats
M Hotte et al.
NEUROBIOLOGY OF LEARNING AND MEMORY (2005)
Differential effects of acute and subchronic administration on phencyclidine-induced neuro degeneration in the perinatal rat
ZW Cheng et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2005)
Serotonin 5-HT1A receptors regulate NMDA receptor channels through a microtubule-dependent mechanism
EY Yuen et al.
JOURNAL OF NEUROSCIENCE (2005)
Cognitive improvement in schizophrenic patients does not require a serotonergic mechanism:: Randomized controlled trial of olanzapine vs amisulpride
M Wagner et al.
NEUROPSYCHOPHARMACOLOGY (2005)
A meta-analysis of neuropsychological change to clozapine, olanzapine, quetiapine, and risperidone in schizophrenia
ND Woodward et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2005)
General and specific cognitive deficits in schizophrenia
D Dickinson et al.
BIOLOGICAL PSYCHIATRY (2004)
Magnitude of dopamine release in medial prefrontal cortex predicts accuracy of memory on a delayed response task
AG Phillips et al.
JOURNAL OF NEUROSCIENCE (2004)
The atypical antipsychotic drug clozapine enhances chronic PCP-induced regulation of prefrontal cortex 5-HT2A receptors
LJ Steward et al.
NEUROPHARMACOLOGY (2004)
Longitudinal studies of cognition and functional outcome in schizophrenia: implications for MATRICS
MF Green et al.
SCHIZOPHRENIA RESEARCH (2004)
5-HT1A and 5-HT2A receptors minimally contribute to clozapine-induced acetylcholine release in rat medial prefrontal cortex
J Ichikawa et al.
BRAIN RESEARCH (2002)
Neurocognitive effects of clozapine, olanzapine, risperidone, and haloperidol in patients with chronic schizophrenia or schizoaffective disorder
RM Bilder et al.
AMERICAN JOURNAL OF PSYCHIATRY (2002)
Enhancement of cognitive performance in schizophrenia by addition of tandospirone to neuroleptic treatment
T Sumiyoshi et al.
AMERICAN JOURNAL OF PSYCHIATRY (2001)
Dopamine receptor polymorphisms and drug response in schizophrenia
J Scharfetter
PHARMACOGENOMICS (2001)
The effect of tandospirone, a serotonin1A agonist, on memory function in schizophrenia
T Sumiyoshi et al.
BIOLOGICAL PSYCHIATRY (2001)
5-HT2A and D2 receptor blockade increases cortical DA release via 5-HT1A receptor activation:: a possible mechanism of atypical antipsychotic-induced cortical dopamine release
J Ichikawa et al.
JOURNAL OF NEUROCHEMISTRY (2001)
Studies of cognitive change in patients with schizophrenia following novel antipsychotic treatment
PD Harvey et al.
AMERICAN JOURNAL OF PSYCHIATRY (2001)
The declarative/procedural model of lexicon and grammar
MT Ullman
JOURNAL OF PSYCHOLINGUISTIC RESEARCH (2001)
Abnormalities in the thalamus and prefrontal cortex during episodic object recognition in schizophrenia
S Heckers et al.
BIOLOGICAL PSYCHIATRY (2000)
Effect of adjunctive treatment with serotonin-1A agonist tandospirone on memory functions in schizophrenia
T Sumiyoshi et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2000)
Role of serotonin in memory impairment
HC Buhot et al.
ANNALS OF MEDICINE (2000)
Effects of repeated phencyclidine treatment on serotonin transporter in rat brain
T Hori et al.
NEUROSCIENCE LETTERS (2000)
Share Paper
